Heterologous prime-boost vaccination targeting MAGE-type antigens promotes tumor T-cell infiltration and improves checkpoint blockade therapy

Código QR

Heterologous prime-boost vaccination targeting MAGE-type antigens promotes tumor T-cell infiltration and improves checkpoint blockade therapy

Guardado en:

Detalles Bibliográficos
Autores principales:	Federica Cappuccini, Emily Pollock, Irina Redchenko, Benoit J Van den Eynde, James McAuliffe, Hok Fung Chan, Laurine Noblecourt, Ramiro Andrei Ramirez-Valdez, Vinnycius Pereira-Almeida, Yaxuan Zhou, Adrian VS Hill, Carol Sze Ki Leung
Formato:	article
Lenguaje:	EN
Publicado:	BMJ Publishing Group 2021
Materias:	Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Acceso en línea:	https://doaj.org/article/76ded580fcd1416c91d0e4737e7a092b
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Assessment of an LSDV-Vectored Vaccine for Heterologous Prime-Boost Immunizations against HIV
por: Ros Chapman, et al.
Publicado: (2021)

Broadly Reactive IgG Responses to Heterologous H5 Prime-Boost Influenza Vaccination Are Shaped by Antigenic Relatedness to Priming Strains
por: Jiong Wang, et al.
Publicado: (2021)

Protective mucosal immunity against SARS-CoV-2 after heterologous systemic prime-mucosal boost immunization
por: Dennis Lapuente, et al.
Publicado: (2021)

Sterile protection against Plasmodium knowlesi in rhesus monkeys from a malaria vaccine: comparison of heterologous prime boost strategies.
por: George Jiang, et al.
Publicado: (2009)

Heterologous prime-boost vaccination with H3N2 influenza viruses of swine favors cross-clade antibody responses and protection
por: Kristien Van Reeth, et al.
Publicado: (2017)

Engineering well-expressed, V2-immunofocusing HIV-1 envelope glycoprotein membrane trimers for use in heterologous prime-boost vaccine regimens.
por: Emma T Crooks, et al.
Publicado: (2021)

Engineering well-expressed, V2-immunofocusing HIV-1 envelope glycoprotein membrane trimers for use in heterologous prime-boost vaccine regimens
por: Emma T. Crooks, et al.
Publicado: (2021)

Enhanced immune response against HIV-1 induced by a heterologous DNA prime-adenovirus boost vaccination using mannosylated polyethyleneimine as DNA vaccine adjuvant
por: Li M, et al.
Publicado: (2013)

CD4 and CD8 T cell responses to the M. tuberculosis Ag85B-TB10.4 promoted by adjuvanted subunit, adenovector or heterologous prime boost vaccination.
por: Tara Elvang, et al.
Publicado: (2009)

Strong immunogenicity of heterologous prime-boost immunizations with the experimental vaccine GRAd-COV2 and BNT162b2 or ChAdOx1-nCOV19
por: Chiara Agrati, et al.
Publicado: (2021)

Structural basis for substrate recognition and chemical inhibition of oncogenic MAGE ubiquitin ligases
por: Seung Wook Yang, et al.
Publicado: (2020)

Effectiveness of heterologous ChAdOx1 nCoV-19 and mRNA prime-boost vaccination against symptomatic Covid-19 infection in Sweden: A nationwide cohort study
por: Peter Nordström, et al.
Publicado: (2021)

A neomorphic cancer cell-specific role of MAGE-A4 in trans-lesion synthesis
por: Yanzhe Gao, et al.
Publicado: (2016)

A comparative test of inequity aversion in domestic dogs (Canis familiaris) and dingoes (Canis dingo).
por: Katherine McAuliffe
Publicado: (2021)

Improvisation as Original Ethics: Exploring the Ethical in Heidegger and Gadamer from a Musical Perspective
por: Sam McAuliffe
Publicado: (2021)

Targeting melanoma with immunoliposomes coupled to anti-MAGE A1 TCR-like single-chain antibody
por: Saeed M, et al.
Publicado: (2016)

Nanoscale Peptide Self-assemblies Boost BCG-primed Cellular Immunity Against Mycobacterium tuberculosis
por: Charles B. Chesson, et al.
Publicado: (2018)

Elicitation of both anti HIV-1 Env humoral and cellular immunities by replicating vaccinia prime Sendai virus boost regimen and boosting by CD40Lm.
por: Xianfeng Zhang, et al.
Publicado: (2012)

A Case Report and Literature Review of a Novel Mutation in the MAGED2 Gene of a Patient With Severe Transient Polyhydramnios
por: Xiaoxia Wu, et al.
Publicado: (2021)

Immunogenicity of prime-boost protein subunit vaccine strategies against SARS-CoV-2 in mice and macaques
por: Hyon-Xhi Tan, et al.
Publicado: (2021)

Serum cytokine profiles associated with specific adjuvants used in a DNA prime-protein boost vaccination strategy.
por: Rachel Buglione-Corbett, et al.
Publicado: (2013)

Radiation combines with immune checkpoint blockade to enhance T cell priming in a murine model of poorly immunogenic pancreatic cancer
por: Courtney T. Stump, et al.
Publicado: (2021)

Targeting MAGE-C1/CT7 expression increases cell sensitivity to the proteasome inhibitor bortezomib in multiple myeloma cell lines.
por: Fabricio de Carvalho, et al.
Publicado: (2011)

Optimisation of prime-boost immunization in mice using novel protein-based and recombinant vaccinia (Tiantan)-based HBV vaccine.
por: Hong Chen, et al.
Publicado: (2012)

Recombinant BCG-Prime and DNA-Boost Immunization Confers Mice with Enhanced Protection against <i>Mycobacterium kansasii</i>
por: Shihoko Komine-Aizawa, et al.
Publicado: (2021)

Adenovirus prime, Env protein boost vaccine protects against neutralization-resistant SIVsmE660 variants in rhesus monkeys
por: Brandon F. Keele, et al.
Publicado: (2017)

Author Correction: Children avoid inefficient but fair partners in a cooperative game
por: Laurent Prétôt, et al.
Publicado: (2020)

Children avoid inefficient but fair partners in a cooperative game
por: Laurent Prétôt, et al.
Publicado: (2020)

Immunogenicity and protective efficacy of prime-boost immunization in mice vaccinated with live and inactivated influenza A (H5N1) vaccines
por: I. Losev, et al.
Publicado: (2019)

Heterologous immune responses in health and disease
por: A. P. Toptygina
Publicado: (2020)

Improved Cascaded H-Bridge Multilevel Inverters with Voltage-Boosting Capability
por: Sze Sing Lee, et al.
Publicado: (2021)

Exploring healthcare staff narratives to understand the role of quality improvement methods in innovative practices during COVID-19
por: Zuneera Khurshid, et al.
Publicado: (2021)

Unconquered by the Blockade
por: E. M. Proshina
Publicado: (2018)

Heterologous Expression of Syntaxin 6 in Saccharomyces cerevisiae
por: GÖTTE,MARTIN, et al.
Publicado: (2002)

Increased B Cell Selection Stringency In Germinal Centers Can Explain Improved COVID-19 Vaccine Efficacies With Low Dose Prime or Delayed Boost
por: Amar K. Garg, et al.
Publicado: (2021)

Development of novel prime-boost strategies based on a tri-gene fusion recombinant L. tarentolae vaccine against experimental murine visceral leishmaniasis.
por: Noushin Saljoughian, et al.
Publicado: (2013)

Diophantine approximation with one prime, two squares of primes and one kth power of a prime
por: Gambini Alessandro
Publicado: (2021)

Combination of immune checkpoint blockade with DNA cancer vaccine induces potent antitumor immunity against P815 mastocytoma
por: Alessandra Lopes, et al.
Publicado: (2018)

Biochemical mechanisms determine the functional compatibility of heterologous genes
por: Andreas Porse, et al.
Publicado: (2018)

Heterologous expression of membrane proteins: choosing the appropriate host.
por: Florent Bernaudat, et al.
Publicado: (2011)